SCHEMBL30427170

SCHEMBL30427170

CCOc1cnc(Br)cc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.60
▸ HSD17B10 Q99714 2/20 0.60
▸ LMNA P02545 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MAPT P10636 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GABRA4 P48169 1/20 0.40
▸ GABRE P78334 1/20 0.40
▸ GABRA6 Q16445 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23535454 1.00 TSHR (0.60) TSHRHSD17B10LMNACYP3A4KDM4E
SCHEMBL30427332 0.85 DPP4 (0.45) TSHRHSD17B10CYP3A4KDM4EKMT2A
SCHEMBL19329324 0.85 DPP4 (0.45) TSHRHSD17B10CYP3A4KDM4EKMT2A
SCHEMBL16333723 0.82 LCK (0.55) TSHRHSD17B10KDM4EMAPTHTT
SCHEMBL31492972 0.82 TSHR (0.41) TSHRHSD17B10KDM4EKMT2AHTT
SCHEMBL31493111 0.82 HSD17B10 (0.41) TSHRHSD17B10KDM4EGABRPGABRD
SCHEMBL31492990 0.80 KDM4E (0.45) LMNAKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2828736 0.79 TSHR (0.75) TSHRHSD17B10LMNACYP3A4KDM4E
SCHEMBL31493053 0.79 TSHR (0.37) TSHRHSD17B10KDM4EMAPTGABRP
SCHEMBL32667097 0.79 TSHR (0.38) TSHRHSD17B10GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433457-A1 HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-09-25 — — EP disclosed
WO-2023092098-A1 HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback